GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaya Holdings Inc (OTCPK:KAYS) » Definitions » Research & Development

KAYS (Kaya Holdings) Research & Development : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Kaya Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Kaya Holdings's Research & Development for the three months ended in Sep. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.


Kaya Holdings Research & Development Historical Data

The historical data trend for Kaya Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaya Holdings Research & Development Chart

Kaya Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kaya Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kaya Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kaya Holdings  (OTCPK:KAYS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Kaya Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Kaya Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Kaya Holdings Business Description

Traded in Other Exchanges
N/A
Address
915 Middle River Drive, Suite 316, Fort Lauderdale, FL, USA, 33304
Kaya Holdings Inc is a holding company. It is focusing on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and CBD products. The company own and operate a medical cannabis dispensary in the United States. Its has produced, distributed, and/or sold a full range of premium cannabis products including flower, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands.

Kaya Holdings Headlines

From GuruFocus